159 related articles for article (PubMed ID: 33400818)
1. The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
Kamphues C; Andreatos N; Kruppa J; Buettner S; Wang J; Sasaki K; Wagner D; Morioka D; Fitschek F; Løes IM; Imai K; Sun J; Poultsides G; Kaczirek K; Lønning PE; Endo I; Baba H; Kornprat P; Aucejo FN; Wolfgang CL; Kreis ME; Weiss MJ; Margonis GA
J Surg Oncol; 2021 Mar; 123(4):939-948. PubMed ID: 33400818
[TBL] [Abstract][Full Text] [Related]
2. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
5. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
6. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
[TBL] [Abstract][Full Text] [Related]
7. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis.
Paro A; Hyer MJ; Tsilimigras DI; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Aucejo F; Cloyd JM; Pawlik TM
J Am Coll Surg; 2022 Apr; 234(4):504-513. PubMed ID: 35290269
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer.
Pian G; Shin JS; Yoon S; Oh SY
Anticancer Res; 2021 Feb; 41(2):1101-1110. PubMed ID: 33517321
[TBL] [Abstract][Full Text] [Related]
10. Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications?
Sasaki K; Margonis GA; Andreatos N; Wilson A; Gani F; Amini N; Pawlik TM
HPB (Oxford); 2016 Dec; 18(12):1000-1009. PubMed ID: 27769662
[TBL] [Abstract][Full Text] [Related]
11. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
12. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
Hohenberger P; Schlag PM; Gerneth T; Herfarth C
Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
[TBL] [Abstract][Full Text] [Related]
13. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
[TBL] [Abstract][Full Text] [Related]
15. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
Margonis GA; Sasaki K; Gholami S; Kim Y; Andreatos N; Rezaee N; Deshwar A; Buettner S; Allen PJ; Kingham TP; Pawlik TM; He J; Cameron JL; Jarnagin WR; Wolfgang CL; D'Angelica MI; Weiss MJ
Br J Surg; 2018 Aug; 105(9):1210-1220. PubMed ID: 29691844
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
Wang YY; Liu ZZ; Xu D; Liu M; Wang K; Xing BC
Ann Surg Oncol; 2019 Oct; 26(11):3682-3692. PubMed ID: 31264117
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
Schmidt T; Nienhüser H; Kuna C; Klose J; Strowitzki MJ; Büchler MW; Ulrich A; Schneider M
Eur J Surg Oncol; 2018 Oct; 44(10):1610-1618. PubMed ID: 30115500
[TBL] [Abstract][Full Text] [Related]
19. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
[TBL] [Abstract][Full Text] [Related]
20. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
